Laura Challinor, senior policy and public affairs manager at Blood Cancer UK, told the British Medical Journal: “As we go into the autumn with covid-19 cases rising and the uncertainty of a new variant, routine testing in healthcare settings should now be reinstated to monitor and mitigate the risk of covid-19 for people with weakened immune systems.”